MedicationCoupons.org: FDA Approves Generic Epiduo Adapalene/Benzoyl Peroxide To Treat Acne Vulgaris

MIAMI - Sept. 6, 2016 - PRLog -- Last week, Perrigo Company PLC stated that it had gained preliminary approval by the US FDA for manufacturing the generic version of Epiduo Gel (adapalene / benzoyl peroxide 0.1% / 2.5% combination).

Epiduo Gel (adapalene with benzoyl peroxide 0.1%/2.5%) is indicated for treating acne vulgaris in adults and adolescents of 12 years of age and older. More specifically, the Adapalene / Benzoyl Peroxide combination is a prescription drug mix for the treatment of severe acne vulgaris.  It is marketed by Galderma under the trade name Epiduo.  In Canada its trade name is TactuPump, while it was previously manufactured under the name Tactuo.  This pharmaceutical combination consists of a mixture of 2 active ingredients, adapalene (0.1%) and benzoyl peroxide (2.5%), in a topical gel form.  Meta-research of clinical investigations has shown this combined therapy to be more effective than either one of its ingredients on their own, thereby indicating a synergistic effect of these two active ingredients.

Perrigo Company PLC is one of the 5 largest international OTC medication manufacturers, which is known for manufacturing high quality, low cost products. Its annual revenues for last year were $379 million.

*Get Epiduo, Adapalene / Benzoyl Peroxide COUPONS at: http://MedicationCoupons.org ->